Atlas Venture Fund XI, L.P. has filed 44 insider transactions across 4 companies since January 2024.
Most recent transaction: a transaction of 2886293 shares of Sionna Therapeutics, Inc. ($SION) on February 10, 2025.
Activity breakdown: 1 open-market purchase and 35 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Common Stock | 2886293 | $0.00 | 3,694,020.0000 | 0 | 357.34% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Series C convertible preferred stock | 1092504 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Series C convertible preferred stock | 61463 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Series B convertible preferred stock | 1298332 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Series A convertible preferred stock | 1806317 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Series Seed convertible preferred stock | 1051051 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | P | Common Stock | 60000 | $18.00 | 3,694,020.0000 | 0 | 1.65% | 0.00% |
| Feb. 10, 2025 | Sionna Therapeutics, Inc. | $SION | Atlas Venture Fund XI, L.P. | Not found | C | Common Stock | 747727 | $0.00 | 3,634,020.0000 | 0 | 25.91% | 0.00% |
| Nov. 1, 2024 | Third Harmonic Bio, Inc. | $THRD | Atlas Venture Fund XI, L.P. | Not found | J | Common Stock | 515688 | $0.00 | 9,798,075.0000 | 0 | 5.00% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 3821 | $24.68 | 7,209,144.0000 | 0 | 0.05% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 136312 | $23.59 | 7,080,737.0000 | 0 | 1.89% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2216 | $24.68 | 6,575,897.0000 | 0 | 0.03% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 152244 | $24.83 | 6,565,008.0000 | 0 | 2.27% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2430 | $25.25 | 6,562,578.0000 | 0 | 0.04% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 22567 | $24.83 | 7,186,577.0000 | 0 | 0.31% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 360 | $25.25 | 7,186,217.0000 | 0 | 0.01% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 13109 | $24.83 | 6,562,788.0000 | 0 | 0.20% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 210 | $25.25 | 6,562,578.0000 | 0 | 0.00% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 23505 | $24.38 | 6,578,113.0000 | 0 | 0.36% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 64783 | $23.98 | 7,015,954.0000 | 0 | 0.91% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 20205 | $23.59 | 7,263,023.0000 | 0 | 0.28% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 9603 | $23.98 | 7,253,420.0000 | 0 | 0.13% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 11736 | $23.59 | 6,607,198.0000 | 0 | 0.18% | 0.00% |
| Feb. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 5580 | $23.98 | 6,601,618.0000 | 0 | 0.08% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 272923 | $24.38 | 6,743,031.0000 | 0 | 3.89% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 25779 | $24.68 | 6,717,252.0000 | 0 | 0.38% | 0.00% |
| Feb. 27, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 40455 | $24.38 | 7,212,965.0000 | 0 | 0.56% | 0.00% |
| Feb. 21, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 149337 | $22.44 | 7,587,471.0000 | 0 | 1.93% | 0.00% |
| Feb. 23, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 13738 | $22.70 | 7,273,405.0000 | 0 | 0.19% | 0.00% |
| Feb. 23, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 23648 | $22.70 | 7,937,699.0000 | 0 | 0.30% | 0.00% |
| Feb. 23, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 159542 | $22.70 | 7,273,405.0000 | 0 | 2.15% | 0.00% |
| Feb. 22, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 119360 | $22.66 | 7,432,947.0000 | 0 | 1.58% | 0.00% |
| Feb. 21, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 35164 | $23.14 | 7,552,307.0000 | 0 | 0.46% | 0.00% |
| Feb. 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 166029 | $22.71 | 6,819,475.0000 | 0 | 2.38% | 0.00% |
| Feb. 15, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2113 | $24.45 | 7,148,211.0000 | 0 | 0.03% | 0.00% |
| Feb. 15, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 175793 | $23.88 | 7,150,324.0000 | 0 | 2.40% | 0.00% |
| Feb. 16, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 162707 | $23.14 | 6,985,504.0000 | 0 | 2.28% | 0.00% |
| Feb. 20, 2024 | Dyne Therapeutics, Inc. | $DYN | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 3510 | $23.40 | 6,815,965.0000 | 0 | 0.05% | 0.00% |
| Feb. 8, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 267 | $0.64 | 2,754,109.0000 | 0 | 0.01% | 0.00% |
| Feb. 8, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 733 | $0.64 | 2,754,109.0000 | 0 | 0.03% | 0.00% |
| Jan. 11, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 1566 | $0.87 | 2,756,649.0000 | 0 | 0.06% | 0.00% |
| Jan. 12, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 1540 | $0.83 | 2,755,109.0000 | 0 | 0.06% | 0.00% |
| Jan. 12, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 560 | $0.83 | 2,755,109.0000 | 0 | 0.02% | 0.00% |
| Jan. 11, 2024 | Xilio Therapeutics, Inc. | $XLO | Atlas Venture Fund XI, L.P. | TenPercentOwner | S | Common Stock | 569 | $0.87 | 2,755,669.0000 | 0 | 0.02% | 0.00% |